Clinical trials: NOTCH Gene Mutation Positive Tumors

Desmoid Tumor, NOTCH Gene Mutation Positive Tumors

Individual Patient Compassionate Use of Nirogacestat

• Available
• Age: All ages
• Expanded access

This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee, and applicable competent authority approval.

Trial name

NCT05041036

Testing

Nirogacestat (Gamma Secretase Inhibitor)

Where

2 sites in United States, Germany

Sponsor

SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany